Výsledky vyhľadávania - "B7-H1 Antigen metabolism"

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Autori: Uppaluri, Ravindra Haddad, Robert I Tao, Yungan a ďalší

Zdroj: New England Journal of Medicine. 393:37-50

Predmety: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality

Popis súboru: application/pdf

Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis

Autori: Peters, Solange Paz-Ares, Luis G. Reck, Martin a ďalší

Prispievatelia: Peters, Solange Paz-Ares, Luis G. Reck, Martin a ďalší

Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of thoracic oncology, vol. 20, no. 1, pp. 94-108

Predmety: PD-L1, Nivolumab, Non–small cell lung cancer, Humans, Nivolumab/pharmacology, Nivolumab/therapeutic use, Nivolumab/administration & dosage, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/mortality, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Lung Neoplasms/mortality, Lung Neoplasms/metabolism, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, Ipilimumab/administration & dosage, Male, Female, Middle Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, B7-H1 Antigen/metabolism, Aged, Adult, Survival Rate, Aged, 80 and over, Follow-Up Studies, Immunotherapy, Ipilimumab

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39369790
http://hdl.handle.net/10261/390933
https://api.elsevier.com/content/abstract/scopus_id/85208360083
https://serval.unil.ch/resource/serval:BIB_89D370D6F09D.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_89D370D6F09D
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_89D370D6F09D7

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Autori: Ferdinandos Skoulidis Haniel A. Araujo Minh Truong Do a ďalší

Zdroj: Nature
Nature, vol. 635, no. 8038, pp. 462-471
Nature, vol 635, iss 8038

Predmety: Male, Lung Neoplasms, General Science & Technology (science-metrix), T-Lymphocytes, Monoclonal (mesh), Drug Resistance, Nitric Oxide Synthase Type II, Phase III as Topic (mesh), Lung (rcdc), B7-H1 Antigen, Mice, AMP-Activated Protein Kinase Kinases, Carcinoma, Non-Small-Cell Lung, Monoclonal, Tumor Microenvironment, Animals (mesh), T-Lymphocytes (mesh), CTLA-4 Antigen, Non-Small-Cell Lung, 32 Biomedical and Clinical Sciences (for-2020), Male (mesh), Immune Checkpoint Inhibitors, Cancer (rcdc), Humans (mesh), Kelch-Like ECH-Associated Protein 1/metabolism, Kelch-Like ECH-Associated Protein 1/genetics, Humans, Animals, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/immunology, Protein Serine-Threonine Kinases/metabolism, Protein Serine-Threonine Kinases/antagonists & inhibitors, Protein Serine-Threonine Kinases/genetics, Immune Checkpoint Inhibitors/pharmacology, Immune Checkpoint Inhibitors/therapeutic use, Drug Resistance, Neoplasm/drug effects, Lung Neoplasms/drug therapy, Lung Neoplasms/genetics, Lung Neoplasms/immunology, Lung Neoplasms/pathology, CTLA-4 Antigen/antagonists & inhibitors, CTLA-4 Antigen/metabolism, B7-H1 Antigen/metabolism, B7-H1 Antigen/antagonists & inhibitors, Female, Mutation, Antibodies, Monoclonal, Kelch-Like ECH-Associated Protein 1, Immune Checkpoint Inhibitors (mesh), Mutation (mesh), Mice (mesh), Tumor Suppressor (mesh), Nitric Oxide Synthase Type II (mesh), Phase III as Topic, Lung Cancer (rcdc), Non-Small-Cell Lung (mesh), Neoplasm (mesh), Tumor Suppressor, Tumor Suppressor Proteins (mesh), Antibodies, Article, CTLA-4 Antigen (mesh), 5.1 Pharmaceuticals (hrcs-rac), Clinical Trials, 3204 Immunology (for-2020), AMP-Activated Protein Kinase Kinases (mesh), Lung Neoplasms (mesh), Kelch-Like ECH-Associated Protein 1 (mesh), Tumor Suppressor Proteins, Carcinoma, Immunotherapy (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), B7-H1 Antigen (mesh), Tumor Microenvironment (mesh), 3211 Oncology and Carcinogenesis (for-2020), Genes, Clinical Trials, Phase III as Topic, Drug Resistance, Neoplasm, Female (mesh), Neoplasm

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39385035
https://serval.unil.ch/notice/serval:BIB_CF6BDAC4D159
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CF6BDAC4D1593
https://serval.unil.ch/resource/serval:BIB_CF6BDAC4D159.P001/REF.pdf
https://escholarship.org/content/qt7qr2m860/qt7qr2m860.pdf
https://escholarship.org/uc/item/7qr2m860

Deutscher Expertenkonsens zur PD-L1-Testung ('programmed cell death ligand 1') in der perioperativen Systemtherapie des muskelinvasiven Blasenkarzinoms

Autori: Niegisch, Günter Bolenz, Christian Doehn, Christian a ďalší

Zdroj: Urologie
Die Urologie, 63(10):1019-1027

Predmety: Übersichten, Muscle invasive bladder carcinoma, Urothelial carcinoma, Perioperative systemic therapy, Humans [MeSH], Urinary Bladder Neoplasms/drug therapy [MeSH], Perioperative Systemtherapie, Perioperative Care/methods [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Neoplasm Invasiveness [MeSH], Cystectomy [MeSH], B7-H1 Antigen/metabolism [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], PD-L1 testing, Urinary Bladder Neoplasms/surgery [MeSH], Urothelkarzinom, B7-H1 Antigen/antagonists, Germany [MeSH], Immune checkpoint inhibitor, Immun-Checkpoint-Inhibitor, PD-L1-Testung, Consensus [MeSH], Muskelinvasives Blasenkarzinom, Immune Checkpoint Inhibitors/pharmacology [MeSH]

Popis súboru: application/pdf

Prístupová URL adresa: https://repository.publisso.de/resource/frl:6518777

PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation

Autori: Daniela Chmiest Silvia Podavini Kalliopi Ioannidou a ďalší

Zdroj: Blood Adv
Blood advances, vol. 8, no. 11, pp. 2908-2923

Predmety: Humans, Phosphorylation, Programmed Cell Death 1 Receptor/metabolism, Protein Kinase C-theta/metabolism, Immunological Synapses/metabolism, Cytoskeletal Proteins/metabolism, T-Lymphocytes/metabolism, T-Lymphocytes/immunology, Protein Kinase C/metabolism, Vimentin/metabolism, B7-H1 Antigen/metabolism, Immunobiology and Immunotherapy, Immunological Synapses, T-Lymphocytes, Programmed Cell Death 1 Receptor, B7-H1 Antigen, 3. Good health, Cytoskeletal Proteins, Protein Kinase C-theta, Vimentin, Protein Kinase C

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38513140
https://serval.unil.ch/notice/serval:BIB_E176D0DCD829
https://serval.unil.ch/resource/serval:BIB_E176D0DCD829.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E176D0DCD8291

PD-L1 expression, tumor-infiltrating lymphocytes, and mismatch repair proteins status in digestive neuroendocrine neoplasms: exploring their potential role as theragnostic and prognostic biomarkers

Autori: Eléonore Multone Stefano La Rosa Christine Sempoux a ďalší

Zdroj: Virchows Arch
Virchows Archiv, vol. 485, no. 5, pp. 841-851

Predmety: Male, Adult, Aged, 80 and over, 0301 basic medicine, Middle Aged, Prognosis, Digestive System Neoplasms, DNA Mismatch Repair, Immunohistochemistry, B7-H1 Antigen, Neuroendocrine Tumors, 03 medical and health sciences, Humans, B7-H1 Antigen/metabolism, Female, Biomarkers, Tumor/analysis, Biomarkers, Tumor/metabolism, Lymphocytes, Tumor-Infiltrating/immunology, Lymphocytes, Tumor-Infiltrating/pathology, Lymphocytes, Tumor-Infiltrating/metabolism, Neuroendocrine Tumors/pathology, Neuroendocrine Tumors/metabolism, Neuroendocrine Tumors/immunology, Aged, Digestive System Neoplasms/pathology, Digestive System Neoplasms/immunology, Digestive System Neoplasms/metabolism, Digestive system, neuroendocrine tumors, neuroendocrine carcinomas, Mismatch repair protein, Neuroendocrine neoplasm, PD-L1, Tumor immune infiltration, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Biomarkers, Tumor, Original Article

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38771338
https://serval.unil.ch/notice/serval:BIB_783A4E0BFABA
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_783A4E0BFABA7
https://serval.unil.ch/resource/serval:BIB_783A4E0BFABA.P001/REF.pdf

Radiation‐Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer Patients

Autori: Gruber, Elisabeth S. Oberhuber, Georg Gurnhofer, Elisabeth a ďalší

Zdroj: Cancer Med
Cancer Medicine, Vol 14, Iss 5, Pp n/a-n/a (2025)

Predmety: Male, Adult, STAT1 Transcription Factor Metabolism, Rectal Neoplasms Metabolism, Indoleamine-Pyrrole 2,3,-Dioxygenase Metabolism, Biomarkers, Tumor, Rectal Neoplasms Genetics, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase, STAT1 Transcription Factor Genetics, B7-H1 Antigen Metabolism, RC254-282, Neoplasm Staging, Aged, B7-H1 Antigen Genetics, Aged, 80 and over, Indoleamine-Pyrrole 2,3,-Dioxygenase Genetics, Rectal Neoplasms, Biomarkers, Tumor Metabolism, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Prognosis, Rectal Neoplasms Pathology, STAT1 Transcription Factor, Rectal Neoplasms Radiotherapy, Female, Research Article

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/40062505
https://doaj.org/article/dcb10b802ba34d61bfa1fb37e969a92d

Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils

Autori: Joaquin M. Pellegrini Gabriela González-Espinoza Raheleh R. Shayan a ďalší

Zdroj: Nat Commun
Nature Communications, Vol 16, Iss 1, Pp 1-16 (2025)

Predmety: Ly -- metabolism, Omentum -- immunology -- metabolism, Neutrophils, Science, T-Lymphocytes, Neutrophils -- immunology -- metabolism, Brucella abortus, CD8-Positive T-Lymphocytes, Inbred C57BL, Article, Brucellosis, B7-H1 Antigen, Monocytes, Mice, Animals, Humans, Antigens, Ly, Antigens, Immune Evasion, T-Lymphocytes -- immunology -- metabolism, Macrophages, Brucellosis -- immunology -- microbiology -- metabolism, Sciences bio-médicales et agricoles, Monocytes -- immunology -- metabolism, Macrophages -- immunology -- metabolism, Mice, Inbred C57BL, Interleukin 1 Receptor Antagonist Protein, B7-H1 Antigen -- metabolism -- genetics, Brucella abortus -- immunology, Female, Omentum

Popis súboru: 2 full-text file(s): application/pdf; application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39833171
https://doaj.org/article/8b32eea2b7ff42bcaf3cbd9d17a63666

Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection

Autori: Wasilewski, David Onken, Julia Höricke, Paul a ďalší

Zdroj: J Neurooncol

Predmety: 0301 basic medicine, PD-L1, Humans [MeSH], Brain Neoplasms/surgery [MeSH], Retrospective Studies [MeSH], Lung Neoplasms/surgery [MeSH], Carcinoma, Non-Small-Cell Lung/surgery [MeSH], B7-H1 Antigen/metabolism [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], NSCLC, Survival, Discordance, Research, Brain metastasis, PFS, Brain Neoplasms/drug therapy [MeSH], Carcinoma, Non-Small-Cell Lung/drug therapy [MeSH], Lung Neoplasms/drug therapy [MeSH], 03 medical and health sciences, Lung Neoplasms, 0302 clinical medicine, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Humans, Immune Checkpoint Inhibitors, B7-H1 Antigen, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38358406
https://repository.publisso.de/resource/frl:6522034

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer

Autori: Eslami-S, Zahra Cortés-Hernández, Luis Enrique Sinoquet, Léa a ďalší

Prispievatelia: Eslami-S, Zahra Cortés-Hernández, Luis Enrique Sinoquet, Léa a ďalší

Zdroj: Br J Cancer

Predmety: Lung Neoplasms, [SDV]Life Sciences [q-bio], Liquid Biopsy, Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Liquid Biopsy [MeSH], B7-H1 Antigen/metabolism [MeSH], 692/4028/67/1612/1350, Article, Extracellular Vesicles/metabolism [MeSH], Neoplastic Cells, Circulating [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], 631/67/1612/1350, Lung Neoplasms/pathology [MeSH], B7-H1 Antigen/genetics [MeSH], article, Prognosis, Neoplastic Cells, Circulating, B7-H1 Antigen, 3. Good health, [SDV] Life Sciences [q-bio], Extracellular Vesicles, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Humans, Prospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37973956
https://hal.inrae.fr/hal-04534617v1/document
https://doi.org/10.1038/s41416-023-02491-9
https://hal.inrae.fr/hal-04534617v1
https://repository.publisso.de/resource/frl:6508158

Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma

Autori: Vestergaard, Cecilie D. Donia, Marco Madsen, Kasper a ďalší

Zdroj: Vestergaard, C D, Donia, M, Madsen, K, Schmidt, H, Luczak, A A, Bastholt, L, Ellebaek, E & Svane, I M 2025, 'Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma', European Journal of Cancer, vol. 221, 115402. https://doi.org/10.1016/j.ejca.2025.115402

Predmety: Anti-CTLA-4, Anti-PD-1, Immunotherapy, Metastatic melanoma, PD-L1 status, Predictive biomarker, Real-world Evidence, Predictive Value of Tests, B7-H1 Antigen/metabolism, Time-to-Treatment, Immune Checkpoint Inhibitors/therapeutic use, Humans, Middle Aged, Male, Skin Neoplasms/pathology, Biopsy, Progression-Free Survival, Melanoma/drug therapy, Aged, 80 and over, Denmark, Female, Adult, Biomarkers, Tumor/metabolism

Popis súboru: application/pdf

Dostupnosť: https://portal.findresearcher.sdu.dk/da/publications/36e428ef-ef40-48b1-9123-83b76833027f
https://doi.org/10.1016/j.ejca.2025.115402
https://findresearcher.sdu.dk/ws/files/288889237/PIIS0959804925001832.pdf

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.

Autori: Cortellini, A. Brunetti, L. Di Fazio, G.R. a ďalší

Zdroj: Journal for immunotherapy of cancer, vol. 13, no. 2

Predmety: Humans, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/mortality, Non-Small-Cell Lung/pathology, Male, Antibodies, Monoclonal, Humanized/therapeutic use, Female, Lung Neoplasms/drug therapy, Lung Neoplasms/mortality, Lung Neoplasms/pathology, Aged, Middle Aged, Registries, B7-H1 Antigen/antagonists & inhibitors, B7-H1 Antigen/metabolism, Antineoplastic Agents, Immunological/therapeutic use, Adult, 80 and over, Immune Checkpoint Inhibitor, Immunotherapy, Lung Cancer

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39904562; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_32FF4EB5874F2; https://serval.unil.ch/notice/serval:BIB_32FF4EB5874F; https://serval.unil.ch/resource/serval:BIB_32FF4EB5874F.P001/REF.pdf

Dostupnosť: https://serval.unil.ch/notice/serval:BIB_32FF4EB5874F
https://doi.org/10.1136/jitc-2024-010674
https://serval.unil.ch/resource/serval:BIB_32FF4EB5874F.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_32FF4EB5874F2

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials : results from the Pembro-real 5Y global registry

Autori: Cortellini, Alessio Brunetti, Leonardo Di Fazio, Giuseppina Rita a ďalší

Zdroj: ISSN: 2051-1426 ; Journal for immunotherapy of cancer, vol. 13, no. 2 (2025) e010674.

Predmety: info:eu-repo/classification/ddc/616, Immune Checkpoint Inhibitor, Immunotherapy, Lung Cancer, Humans, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / mortality, Non-Small-Cell Lung / pathology, Male, Antibodies, Monoclonal, Humanized / therapeutic use, Female, Lung Neoplasms / drug therapy, Lung Neoplasms / mortality, Lung Neoplasms / pathology, Aged, Middle Aged, Registries, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / metabolism, Antineoplastic Agents, Immunological / therapeutic use, Adult, 80 and over

Relation: info:eu-repo/semantics/altIdentifier/pmid/39904562; unige:183983

Dostupnosť: https://archive-ouverte.unige.ch/unige:183983

Brucella abortus impairs T lymphocyte responsiveness by mobilizing IL-1RA-secreting omental neutrophils.

Autori: Pellegrini, Joaquin JM González-Espinoza, Gabriela Shayan, Raheleh RR a ďalší

Zdroj: Nature communications, 16 (1

Predmety: Sciences bio-médicales et agricoles, Animals, Neutrophils -- immunology -- metabolism, Brucella abortus -- immunology, Brucellosis -- immunology -- microbiology -- metabolism, Omentum -- immunology -- metabolism, Mice, Macrophages -- immunology -- metabolism, Humans, Inbred C57BL, B7-H1 Antigen -- metabolism -- genetics, Female, T-Lymphocytes -- immunology -- metabolism, Antigens, Ly -- metabolism, Monocytes -- immunology -- metabolism

Popis súboru: 2 full-text file(s): application/pdf | application/pdf

Relation: uri/info:pmid/39833171; uri/info:scp/85216439646; uri/info:pmcid/PMC11747348; https://dipot.ulb.ac.be/dspace/bitstream/2013/387366/4/444999.pdf; https://dipot.ulb.ac.be/dspace/bitstream/2013/387366/3/NatureCommunication.pdf

Dostupnosť: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/387366
https://dipot.ulb.ac.be/dspace/bitstream/2013/387366/4/444999.pdf
https://dipot.ulb.ac.be/dspace/bitstream/2013/387366/3/NatureCommunication.pdf

Engineered biomimetic cisplatin-polyphenol nanocomplex for chemo-immunotherapy of glioblastoma by inducing pyroptosis

Autori: Hao, Xinyan Tang, Yucheng Xu, Wenjie a ďalší

Prispievatelia: Hao, Xinyan Tang, Yucheng Xu, Wenjie a ďalší

Predmety: Pyroptosis/drug effects, Cisplatin/pharmacology, Glioblastoma/drug therapy, Animals, Humans, Mice, Cell Line, Tumor, Polyphenols/pharmacology, Immunotherapy/methods, Antineoplastic Agents/pharmacology, Brain Neoplasms/drug therapy, Biomimetic Materials/chemistry, Inbred BALB C, Nude, B7-H1 Antigen/metabolism, Programmed Cell Death 1 Receptor/metabolism, Biomimetics/methods

Relation: PURE: 106921477; PubMed: 39810130; Scopus: 85215759625; http://hdl.handle.net/10362/177597

Dostupnosť: http://hdl.handle.net/10362/177597
https://doi.org/10.1186/s12951-025-03091-w

PD-L1 expression and characterization of its carrier macrophages in placentas with acute and specifically post-SARS-CoV-2 infection

Autori: Seefried, Marina C. Mittelberger, Johanna Franitza, Manuela a ďalší

Zdroj: Histochem Cell Biol

Predmety: Male, Adult, 0301 basic medicine, ddc:610, Original Paper, SARS-CoV-2, Placenta, Macrophages, COVID-19, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, B7-H1 Antigen, COVID-19/immunology [MeSH], PD-L1, Antigens, Differentiation, Myelomonocytic/metabolism [MeSH], CD163, Macrophages/pathology [MeSH], Extravillous trophoblast, Macrophages/metabolism [MeSH], SARS-CoV-2 infection, Antigens, Differentiation, Myelomonocytic/analysis [MeSH], B7-H1 Antigen/metabolism [MeSH], COVID-19/pathology [MeSH], Placenta/virology [MeSH], Macrophages/immunology [MeSH], Male [MeSH], CD68 Molecule [MeSH], Placenta/metabolism [MeSH], Receptors, Cell Surface/metabolism [MeSH], SARS-CoV-2 [MeSH], Receptors, Cell Surface/analysis [MeSH], Female [MeSH], B7-H1 Antigen/analysis [MeSH], Adult [MeSH], Humans [MeSH], Macrophages/virology [MeSH], Pregnancy Complications, Infectious/pathology [MeSH], Pregnancy Complications, Infectious/metabolism [MeSH], Placenta/pathology [MeSH], Pregnancy Complications, Infectious/virology [MeSH], COVID-19/metabolism [MeSH], Pregnancy [MeSH], Antigens, CD/metabolism [MeSH], CD163 Antigen, 03 medical and health sciences, 0302 clinical medicine, Pregnancy, Antigens, CD, CD68 Molecule, Humans, Female, Pregnancy Complications, Infectious

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39589546
https://repository.publisso.de/resource/frl:6523796

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer

Autori: Alečković, Maša Li, Zheqi Zhou, Ningxuan a ďalší

Prispievatelia: Alečković, Maša Li, Zheqi Zhou, Ningxuan a ďalší

Zdroj: Mol Cancer Ther

Predmety: B7-H1 Antigen/metabolism, Cancer Research, Paclitaxel, Oncologie, Nuclear Proteins, Triple Negative Breast Neoplasms/pathology, Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors/therapeutic use, Sciences de la santé humaine, B7-H1 Antigen, 3. Good health, Paclitaxel/pharmacology, Paclitaxel/therapeutic use, Mice, Oncology, Immunotherapy/methods, Humans, Animals, Small Molecule Therapeutics, Immunotherapy, Human health sciences, Immune Checkpoint Inhibitors, Transcription Factors

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37676980
https://hdl.handle.net/2268/317136
https://doi.org/10.1158/1535-7163.MCT-23-0303

5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy

Autori: Birgitte Bjørnhart Mette Thune Mouritzen Charlotte Kristiansen a ďalší

Zdroj: Bjørnhart, B, Mouritzen, M T, Kristiansen, C, Schytte, T, Wedervang, K, Pøhl, M & Holmskov Hansen, K 2023, '5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy', Acta Oncologica, vol. 62, no. 8, pp. 861-870. https://doi.org/10.1080/0284186X.2023.2238544

Predmety: B7-H1 Antigen/metabolism, PD-L1, Lung Neoplasms, Denmark, Carcinoma, Immune checkpoint inhibitor, Immune Checkpoint Inhibitors/therapeutic use, survival, Denmark/epidemiology, B7-H1 Antigen, 3. Good health, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms/pathology, performance status, Humans, Non-Small-Cell Lung/pathology, Immune Checkpoint Inhibitors, non-small cell lung cancer, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37534770
https://vbn.aau.dk/da/publications/28deadc4-f96f-4e73-a3fd-2fcadc1fa227
https://doi.org/10.1080/0284186X.2023.2238544
http://www.scopus.com/inward/record.url?scp=85166743059&partnerID=8YFLogxK
https://portal.findresearcher.sdu.dk/da/publications/8dbc4d72-a22c-411b-99a5-9249b32954e8
https://doi.org/10.1080/0284186X.2023.2238544

Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

Autori: Martin Reck Tudor-Eliade Ciuleanu Jong-Seok Lee a ďalší

Prispievatelia: Martin Reck Tudor-Eliade Ciuleanu Jong-Seok Lee a ďalší

Zdroj: Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of thoracic oncology, vol. 18, no. 8, pp. 1055-1069

Predmety: Adult, Lung Neoplasms, Brain Neoplasms, Humans, Nivolumab/pharmacology, Nivolumab/therapeutic use, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, B7-H1 Antigen/metabolism, Lung Neoplasms/pathology, Neoplasm Recurrence, Local/drug therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/chemically induced, Brain Neoplasms/drug therapy, Brain Neoplasms/secondary, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Brain metastases, Intracranial outcomes, Ipilimumab, NSCLC, Nivolumab, B7-H1 Antigen, 3. Good health, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Recurrence, Local

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37146754
http://hdl.handle.net/10261/353291
https://serval.unil.ch/resource/serval:BIB_9890E6F11421.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_9890E6F11421
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9890E6F114218

Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo

Autori: Yuji Yamaguchi Elena Peeva Ester Del Duca a ďalší

Zdroj: Arch Dermatol Res
Archives of Dermatological Research, vol 316, iss 7

Predmety: Oral, Biomarkers, Double-Blind Method [MeSH], Chemokine CXCL9/blood [MeSH], Chemokine CCL5/blood [MeSH], Interferon-gamma [MeSH], Skin Pigmentation/drug effects [MeSH], Administration, Oral [MeSH], B7-H1 Antigen/metabolism [MeSH], Vitiligo/immunology [MeSH], Male [MeSH], Ritlecitinib, Vitiligo/drug therapy [MeSH], JAK inhibitor, Janus Kinase 3/antagonists, Female [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Protein Kinase Inhibitors/administration, Vitiligo/diagnosis [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Vitiligo, B7-H1 Antigen/antagonists, Original Paper, Young Adult [MeSH], B7-H1 Antigen/blood [MeSH], Melanocytes/drug effects [MeSH], Non-segmental vitiligo, Male, Adult, Administration, Oral, Skin Pigmentation, Chemokine CXCL9, B7-H1 Antigen, Young Adult, Interferon-gamma, Double-Blind Method, Humans, Protein Kinase Inhibitors, Chemokine CCL5, Janus Kinase 3, Middle Aged, 3. Good health, Treatment Outcome, Administration, Melanocytes, Female

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39023568
https://repository.publisso.de/resource/frl:6520133
https://escholarship.org/content/qt3qz833wt/qt3qz833wt.pdf
https://escholarship.org/uc/item/3qz833wt